CN106866630B - A kind of preparation method of R-lansoprazole - Google Patents

A kind of preparation method of R-lansoprazole Download PDF

Info

Publication number
CN106866630B
CN106866630B CN201710214873.6A CN201710214873A CN106866630B CN 106866630 B CN106866630 B CN 106866630B CN 201710214873 A CN201710214873 A CN 201710214873A CN 106866630 B CN106866630 B CN 106866630B
Authority
CN
China
Prior art keywords
minutes
room temperature
water
compound
reaction kettle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710214873.6A
Other languages
Chinese (zh)
Other versions
CN106866630A (en
Inventor
刘敏钊
徐艳梅
王进
陈良强
彭志红
刘朝霞
朱晓娟
郑云丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HUAYUAN MEDICINE SCIENCE AND TECHNOLOGY DEVELOPMENT Co Ltd SHANGHAI
Original Assignee
HUAYUAN MEDICINE SCIENCE AND TECHNOLOGY DEVELOPMENT Co Ltd SHANGHAI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUAYUAN MEDICINE SCIENCE AND TECHNOLOGY DEVELOPMENT Co Ltd SHANGHAI filed Critical HUAYUAN MEDICINE SCIENCE AND TECHNOLOGY DEVELOPMENT Co Ltd SHANGHAI
Priority to CN201710214873.6A priority Critical patent/CN106866630B/en
Publication of CN106866630A publication Critical patent/CN106866630A/en
Application granted granted Critical
Publication of CN106866630B publication Critical patent/CN106866630B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention discloses a kind of preparation methods of R-lansoprazole:(1) prepare compound III;(2) R-lansoprazole crude product is prepared;(3) R-lansoprazole crude product is refined.The key point of the present invention is, in step 1 of the present invention, in the compound 2 that charcoal treated is added in 1~1.5 hour so that the reaction was complete, yield improves.In step 2 of the present invention, at 60~65 DEG C, makes to form enough complex compounds in isopropyl titanate (IV) or tert-butyl alcohol titanium are added in 10~15 minutes, content of isomer can be reduced to improve yield and purity.The technological operation of the present invention is simple, and product yield is higher, and purity is higher, conducive to commercially producing.

Description

A kind of preparation method of R-lansoprazole
Technical field
The present invention relates to a kind of preparation methods of R-lansoprazole, belong to pharmaceutical field.
Background technology
R-lansoprazole is proton pump inhibitor.Proton pump inhibitor is benzimidazoles derivative, specific and non-competing Striving property acts on H+/K+-ATP enzymes, treats peptic ulcer.Proton pump inhibitor is mostly fat-soluble alkalescent, absorbed into serum Entering afterwards in parietal cell secretory tubyle, small envelope chamber after acidic environment, activation products are generally active sulfenic acids and sulfenamide, It is coupled to form an irreversible covalent disulfide bonds with H+-K+-ATP enzyme sulfydryls, H+-K+ transporting mechanisms is blocked, to inhibit Gastric acid secretion.
Patent CN1150186 (patent families US6462058,6664276) discloses a kind of HPLC methods and prepares right Lan Suola The method of azoles:That is, at room temperature, Lansoprazole racemic modification being dissolved in suitable solvent, then solution by portions is added Chiralcel OD columns, are eluted with mobile phase, and eluent is checked in 285nm, are merged the shorter optical isomer of retention time and are evaporated Point, concentration merges every batch of fraction, is dissolved in ethyl alcohol, is filtered by 0.45 μm of filter.Hexane is added, evaporation filtrate obtains to doing The amorphous substance of R (+)-Lansoprazole.Obtained amorphous substance is crystallized in different solvents or water, obtains right Lan Suola Azoles crystal or its hydrate (0.5 water~5.0 water).
Patent US6462058, CN95194956 discloses a kind of method that asymmetric oxidation is synthetically prepared R-lansoprazole: That is, Lansoprazole is dissolved in toluene, water, (-)-D- ethyl tartrates and isopropyl titanate are then sequentially added into solution (IV), 50 DEG C are warming up to, stirring is cooled to room temperature after sixty minutes, and diisopropylethylamine and cumene hydroperoxide, stirring is then added 16 hours.Toluene is added into the mixture, acquired solution ammonium hydroxide extracts three times, and combined water layer is by being added spirit acid It neutralizes, by extraction, evaporation and the isolated Lansoprazole of flash chromatography.The residue acetonitrile treatment, obtains sediment, Filtering, filtrate is evaporated, the optical purity grease being improved, and is repeated this process two or three times, is obtained requiredization of oily Close object.
Patent WO97/02261 (11-JP508590) discloses one kind by a kind of enantiomer of enrichment to prepare optical voidness production A kind of method of product, including will be enriched in the product of enantiomer and be added in another solvent, using the cleanliness factor of racemic compound, A kind of racemic compound is settled out from the solvent;It is filtered to remove the racemic compound of precipitation;Then solvent is removed to obtain The single enantiomer of high optical rotation.
Patent US7285668 (patent families CN1254473C), US6462058, WO2009113696 (patent families US8222422), CN1254473C etc. is disclosed prepares R-lansoprazole crystal, R-lansoprazole by amorphous dexlansoprazole The method of hydrate (0.5 water~5 water) and R-lansoprazole hydrate, is included in differential responses temperature, different solvents Middle crystallization is to obtain the R-lansoprazole of expected crystal form.
The chiral column separation method right side of what patent CN1150186 was announced prepare R-lansoprazole is not only time-consuming but also cost Height is unfavorable for commodity production.
The asymmetric oxidation method yield for preparing R-lansoprazole of patent US6462058, CN95194956 announcement is low, if oxygen It is improper to change control, is also easy to produce excessive thioether and sulfone impurity.
The present invention is directed to develop the few R-lansoprazole production technology of a kind of easy to operate, high income, impurity.
Invention content
In view of the shortcomings of the prior art, the present invention relates to the few R-lansoprazole lifes of a kind of easy to operate, high income, impurity Production. art.
A kind of preparation method of R-lansoprazole, its step are as follows:
(1) prepare compound III
At room temperature in input purified water (455L), sodium hydroxide (22.4kg) and compound 1 (35kg) to reaction kettle, then In the compound 2 that charcoal treated is added in 1~1.5 hour, then reaction 1.5 hours, centrifugation is kept to use 35L in room temperature Water rinses, and spin is about 1 hour dry, dry.Then dried material and toluene (315L) are put into reaction kettle, are warming up to reflux, It maintains the reflux for about being cooled to room temperature after twenty minutes, be kept for about 30 minutes.Centrifugation is rinsed with 35L water, and spin is about 1.5 hours dry, Dry compound 3.Yield about 96.0%;
The compound 2 of activated carbon processing:Check the cleanliness factor of reaction kettle, input purified water (350L) and compound 2 (67.6kg) makes compound 2 be completely dissolved in 90 minutes to reaction kettle, stir about, and input activated carbon (3.5kg), stir about 30 divides Clock;
Reaction equation is as follows:
(2) R-lansoprazole crude product is prepared
It puts into toluene (375L) and compound 3 (75kg) to reaction kettle, be warming up to reflux and kept for about 60 minutes, in nitrogen Cooling reaction mass puts into 0.6L water and L- (+)-ethyl tartrate (33.6kg) to room temperature under gas shielded, it is warming up to 60~ 65 DEG C, in isopropyl titanate (IV) (21.6kg) or tert-butyl alcohol titanium (18.5kg) is added in 10~15 minutes after heat preservation about 15 minutes, About 50 minutes postcoolings of insulation reaction to room temperature (is kept in a nitrogen environment until TLC results meet regulation), puts into diisopropyl Cumene hydroperoxide (46.4kg) is then added in base ethamine (17.8kg) in about 30 minutes, keeps reaction about 3.5 hours.Room Temperature is lower to be added hypo solution 1, and stir about stands 10 minutes after ten minutes, detaches bottom aqueous layer, continues to use thiosulfuric acid Sodium solution 2 and 3 washs, and detaches bottom aqueous layer.
Hypo solution 1:At room temperature, input water (300L) and sodium thiosulfate (90kg), stir about make for 15 minutes It is completely dissolved.
Hypo solution 2:At room temperature, input water (150L) and sodium thiosulfate (15kg), stir about make for 15 minutes It is completely dissolved.
Hypo solution 3:At room temperature, input water (150L) and sodium thiosulfate (15kg), stir about make for 15 minutes It is completely dissolved.
Above-mentioned organic layer is put into reaction kettle, is warming up to 30~35 DEG C, input water (94L), then in 10~15 minutes Methyl tertiary butyl ether(MTBE) (187.5L) is added, hexamethylene (375L) is then added in 10~15 minutes, stirring is no more than 40 minutes. Centrifugation, is washed with methyl tertiary butyl ether(MTBE) (75L), and spin is about 1.5 hours dry.It takes gained wet stock to reaction kettle, throws at room temperature Enter acetone (375L), after ten minutes in putting into 1125L water in 30~45 minutes, stir about centrifuges stir about after 30 minutes, uses 75L Water washing, spin obtain R-lansoprazole crude product in dry about 1.5 hours.Yield 83.0%.
(3) R-lansoprazole crude product is refined:
At room temperature, it puts into acetone (300L) and gained wet product to reaction kettle, stirring puts into ammonia spirit (1.5L) above, Next input activated carbon (3.75kg).Filtering is rinsed with acetone (37.5L), is collected in filtrate to reaction kettle.It is molten to put into ammonium hydroxide Then liquid (7.5L), centrifugation use 0.75L water washings with 75L water washings, drying of spinning.Put into dichloromethane (600L) and wet object Material is stood to reaction kettle after stirring, detaches bottom organic layer, dry with sodium thiosulfate (37.5kg).It is distilled off organic molten Agent, input acetone (60L), is distilled off solvent, and acetone (60L) is put into after being cooled to room temperature, and stirring makes to be completely dissolved.Input is just Heptane (600L) filters after being warming up to 40~45 DEG C, stands about 30 minutes.Centrifugation, is washed with normal heptane (30L), drying of spinning About 1.5 hours.Discharging is warming up to 35~40 DEG C, obtains R-lansoprazole within dry about 5 hours.
The key point of the present invention is, in step 1 of the present invention, in the chemical combination that charcoal treated is added in 1~1.5 hour So that the reaction was complete, yield improves object 2.
In step 2 of the present invention, at 60~65 DEG C, make shape in isopropyl titanate (IV) or tert-butyl alcohol titanium are added in 10~15 minutes At enough complex compounds, content of isomer can be reduced to improve yield and purity.
Advantages of the present invention:
The technological operation of the present invention is simple, and product yield is higher, and purity is higher, conducive to commercially producing.
Specific implementation mode
The embodiment of the present invention is described below in detail, the embodiment is only used for explaining the present invention, and should not be understood as pair The limitation of the present invention.
Specific embodiments of the present invention are as described below.
Embodiment 1
A kind of preparation method of R-lansoprazole, its step are as follows:
(1) prepare compound III
At room temperature in input purified water (455L), sodium hydroxide (22.4kg) and compound 1 (35kg) to reaction kettle, then In the compound 2 that charcoal treated is added in 1~1.5 hour, then reaction 1.5 hours, centrifugation is kept to use 35L in room temperature Water rinses, and spin is about 1 hour dry, dry.Then dried material and toluene (315L) are put into reaction kettle, are warming up to reflux, It maintains the reflux for about being cooled to room temperature after twenty minutes, be kept for about 30 minutes.Centrifugation is rinsed with 35L water, and spin is about 1.5 hours dry, Dry compound 3.Yield about 96.0%;
The compound 2 of activated carbon processing:Check the cleanliness factor of reaction kettle, input purified water (350L) and compound 2 (67.6kg) makes compound 2 be completely dissolved in 90 minutes to reaction kettle, stir about, and input activated carbon (3.5kg), stir about 30 divides Clock;
Reaction equation is as follows:
(2) R-lansoprazole crude product is prepared
It puts into toluene (375L) and compound 3 (75kg) to reaction kettle, be warming up to reflux and kept for about 60 minutes, in nitrogen Cooling reaction mass puts into 0.6L water and L- (+)-ethyl tartrate (33.6kg) to room temperature under gas shielded, it is warming up to 60~ 65 DEG C, in isopropyl titanate (IV) (21.6kg) is added in 10~15 minutes after keeping the temperature about 15 minutes, insulation reaction is after about 50 minutes It is cooled to room temperature and (keeps in a nitrogen environment until TLC results meet regulation), input diisopropylethylamine (17.8kg), then Cumene hydroperoxide (46.4kg) is added in about 30 minutes, keeps reaction about 3.5 hours.It is molten that sodium thiosulfate is added at room temperature Liquid 1, stir about stand 10 minutes after ten minutes, detach bottom aqueous layer, continue to be washed with hypo solution 2 and 3, detach bottom Portion's water layer.
Hypo solution 1:At room temperature, input water (300L) and sodium thiosulfate (90kg), stir about make for 15 minutes It is completely dissolved.
Hypo solution 2:At room temperature, input water (150L) and sodium thiosulfate (15kg), stir about make for 15 minutes It is completely dissolved.
Hypo solution 3:At room temperature, input water (150L) and sodium thiosulfate (15kg), stir about make for 15 minutes It is completely dissolved.
Above-mentioned organic layer is put into reaction kettle, is warming up to 30~35 DEG C, input water (94L), then in 10~15 minutes Methyl tertiary butyl ether(MTBE) (187.5L) is added, hexamethylene (375L) is then added in 10~15 minutes, stirring is no more than 40 minutes. Centrifugation, is washed with methyl tertiary butyl ether(MTBE) (75L), and spin is about 1.5 hours dry.It takes gained wet stock to reaction kettle, throws at room temperature Enter acetone (375L), after ten minutes in putting into 1125L water in 30~45 minutes, stir about centrifuges stir about after 30 minutes, uses 75L Water washing, spin obtain R-lansoprazole crude product in dry about 1.5 hours.Yield 83.0%.
(3) R-lansoprazole crude product is refined:
At room temperature, it puts into acetone (300L) and gained wet product to reaction kettle, stirring puts into ammonia spirit (1.5L) above, Next input activated carbon (3.75kg).Filtering is rinsed with acetone (37.5L), is collected in filtrate to reaction kettle.It is molten to put into ammonium hydroxide Then liquid (7.5L), centrifugation use 0.75L water washings with 75L water washings, drying of spinning.Put into dichloromethane (600L) and wet object Material is stood to reaction kettle after stirring, detaches bottom organic layer, dry with sodium thiosulfate (37.5kg).It is distilled off organic molten Agent, input acetone (60L), is distilled off solvent, and acetone (60L) is put into after being cooled to room temperature, and stirring makes to be completely dissolved.Input is just Heptane (600L) filters after being warming up to 40~45 DEG C, stands about 30 minutes.Centrifugation, is washed with normal heptane (30L), drying of spinning About 1.5 hours.Discharging is warming up to 35~40 DEG C, obtains R-lansoprazole within dry about 5 hours.Yield 38.0%.
In triplicate, average result is taken:
Sulfone impurity:Less than 0.15%
Sulphur impurity:Less than 0.15%
Any nonspecific impurity:Less than 0.10%
S- isomer impurities:0.13%
Content:98.0%~102.0%.
Embodiment 2
With embodiment 1, but step 2 is added without isopropyl titanate.
In triplicate, average result is taken:
The yield 65.3% of step 2.
Sulfone impurity:Less than 0.15%
Sulphur impurity:Less than 0.15%
Any nonspecific impurity:Less than 0.10%
S- isomer impurities:0.19%
Content:93.1%
Embodiment 3:
With embodiment 1, but isopropyl titanate changes tert-butyl alcohol titanium (18.5kg) into.
In triplicate, average result is taken:
The yield 71.6% of step 2.
Sulfone impurity:Less than 0.15%
Sulphur impurity:Less than 0.15%
Any nonspecific impurity:Less than 0.10%
S- isomer impurities:0.21%
Content:89.5%
Embodiment 4
With embodiment 1, but isopropyl titanate changes tert-butyl alcohol titanium (5kg) and isopropyl titanate (18.3kg) into.
In triplicate, average result is taken:
The yield 96.3% of step 2.
Sulfone impurity:Less than 0.15%
Sulphur impurity:Less than 0.15%
Any nonspecific impurity:Less than 0.10%
S- isomer impurities:0.08%
Content:101.1%
As it can be seen that under the proportioning of this tert-butyl alcohol titanium and isopropyl titanate, yield is greatly improved.
Embodiment 5
With embodiment 1, but isopropyl titanate changes tert-butyl alcohol titanium (16.8kg) and isopropyl titanate (9.3kg) into.
In triplicate, average result is taken:
The yield 87.6% of step 2.
Sulfone impurity:Less than 0.15%
Sulphur impurity:Less than 0.15%
Any nonspecific impurity:Less than 0.10%
S- isomer impurities:0.01%
Content:101.1%.
As it can be seen that under the proportioning of this tert-butyl alcohol titanium and isopropyl titanate, yield raising is relatively limited, but S- isomer impurities It is greatly lowered.
It should be noted that the foregoing is merely the preferred specific embodiment of the present invention,
If conception under this invention changes, the function generated, the spirit still covered without departing from specification When, it should all be within the scope of the invention.
In the description of this specification, reference term " one embodiment ", " some embodiments ", " example ", " specifically show The description of example " or " some examples " etc. means specific features, structure, material or spy described in conjunction with this embodiment or example Point is included at least one embodiment or example of the invention.In the present specification, schematic expression of the above terms are not Centainly refer to identical embodiment or example.Moreover, particular features, structures, materials, or characteristics described can be any One or more embodiments or example in can be combined in any suitable manner.
Although an embodiment of the present invention has been shown and described, it will be understood by those skilled in the art that:Not In the case of being detached from the principle of the present invention and objective a variety of change, modification, replacement and modification can be carried out to these embodiments, this The range of invention is limited by claim and its equivalent.

Claims (2)

1. a kind of preparation method of R-lansoprazole, its step are as follows:
(1) prepare compound 3
It puts into purified water, sodium hydroxide and compound 1 to reaction kettle at room temperature, then in addition in 1~1.5 hour through activity The compound 2 of charcoal processing then keeps reaction 1.5 hours, centrifugation to be rinsed with 35L water in room temperature, and spin is about 1 hour dry, does It is dry;Then dried material and toluene are put into reaction kettle, is warming up to reflux, maintains the reflux for about being cooled to room temperature after twenty minutes, protected It holds about 30 minutes;Centrifugation is rinsed with 35L water, dry about 1.5 hours of spin, dry compound 3;
The compound 2 of activated carbon processing:It checks the cleanliness factor of reaction kettle, puts into purified water and compound 2 to reaction kettle, stir about So that compound 2 is completely dissolved within 90 minutes, puts into activated carbon, stir about 30 minutes;The compound 1 is 2- mercapto-benzimidazoles, Molecular formula is C7H6N2S;Structural formula is:
The compound 2 is 2- (chloromethyl) -3- methyl -4- (2,2,2- trifluoro ethoxy) pyridine hydrochloride, and molecular formula is C9H10Cl2F3NO;Structural formula is:
The compound 3 is 2- [[[3- methyl -4- (2,2,2- trifluoro ethoxies) -2- pyridyl groups] methyl] is thio] -1H- benzos Imidazoles, molecular formula C16H14F3N3OS, structural formula are:
(2) R-lansoprazole crude product is prepared
It puts into toluene and compound 3 to reaction kettle, be warming up to reflux and kept for about 60 minutes, cooling reaction under nitrogen protection Material puts into water and L- (+)-ethyl tartrate to room temperature, is warming up to 60~65 DEG C, in 10~15 points after keeping the temperature about 15 minutes Be added isopropyl titanate and tert-butyl alcohol titanium in clock, about 50 minutes postcoolings of insulation reaction to room temperature, keep in a nitrogen environment until TLC results meet regulation, put into diisopropylethylamine, and cumene hydroperoxide is then added in about 30 minutes, keep reaction about 3.5 hour;Hypo solution 1 is added at room temperature, stir about stands 10 minutes after ten minutes, detaches bottom aqueous layer, continues It is washed with hypo solution 2 and 3, detaches bottom aqueous layer;Reaction terminates to obtain R-lansoprazole;
Above-mentioned organic layer is put into reaction kettle, is warming up to 30~35 DEG C, water is put into, methyl- tert then is added in 10~15 minutes Butyl ether, is then added hexamethylene in 10~15 minutes, and stirring is no more than 40 minutes;Centrifugation, is washed with methyl tertiary butyl ether(MTBE), Spin is about 1.5 hours dry;It takes gained wet stock to reaction kettle, puts into acetone at room temperature, stir about is after ten minutes in 30~45 1125L water is put into minute, stir about centrifuges after 30 minutes, and with 75L water washings, spin obtains right Lan Suola in dry about 1.5 hours Azoles crude product;
Wherein, the hypo solution 1:At room temperature, put into 300L water and 90kg sodium thiosulfate, stir about makes for 15 minutes It is completely dissolved;
Hypo solution 2:At room temperature, put into 150L water and 15kg sodium thiosulfate, stir about makes to be completely dissolved for 15 minutes;
Hypo solution 3:At room temperature, put into 150L water and 15kg sodium thiosulfate, stir about makes to be completely dissolved for 15 minutes.
2. method described in claim 1, it is characterised in that:
Still further comprise the refined of (3) R-lansoprazole crude product:
At room temperature, it puts into acetone and gained wet product to reaction kettle, stirring puts into ammonia spirit, next put into activated carbon above; Filtering is collected with acetone rinsing in filtrate to reaction kettle, and ammonia spirit is put into, and centrifugation with 75L water washings, then uses 0.75L Water washing, drying of spinning;Dichloromethane and wet stock are put into reaction kettle, is stood after stirring, bottom organic layer is detached, use is thio Sodium sulphate is dried;Organic solvent is distilled off, puts into acetone, solvent is distilled off, acetone is put into after being cooled to room temperature, stirring makes It is completely dissolved;Normal heptane is put into, filtered after being warming up to 40~45 DEG C, stand about 30 minutes;Centrifugation, is washed with normal heptane, is spinned It is about 1.5 hours dry;Discharging is warming up to 35~40 DEG C, must refine R-lansoprazole within dry about 5 hours.
CN201710214873.6A 2017-04-01 2017-04-01 A kind of preparation method of R-lansoprazole Active CN106866630B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710214873.6A CN106866630B (en) 2017-04-01 2017-04-01 A kind of preparation method of R-lansoprazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710214873.6A CN106866630B (en) 2017-04-01 2017-04-01 A kind of preparation method of R-lansoprazole

Publications (2)

Publication Number Publication Date
CN106866630A CN106866630A (en) 2017-06-20
CN106866630B true CN106866630B (en) 2018-08-07

Family

ID=59160696

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710214873.6A Active CN106866630B (en) 2017-04-01 2017-04-01 A kind of preparation method of R-lansoprazole

Country Status (1)

Country Link
CN (1) CN106866630B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107141280A (en) * 2017-07-10 2017-09-08 长沙康普大药房有限责任公司 A kind of preparation method of Dexlansoprazole
CN108440501A (en) * 2018-04-19 2018-08-24 湖北省医药工业研究院有限公司 The preparation method of proton pump inhibitor R-lansoprazole
CN114163419A (en) * 2021-12-24 2022-03-11 辰欣药业股份有限公司 Preparation method of lansoprazole

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1157614A (en) * 1994-07-15 1997-08-20 阿斯特拉公司 Process for synthesis of substituted sulphoxides
CN102558148A (en) * 2010-12-15 2012-07-11 山东方明药业股份有限公司 Synthesis process of lansoprazole important intermediate
CN106543146A (en) * 2016-11-10 2017-03-29 石家庄市度智医药科技有限公司 A kind of preparation method of R-lansoprazole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI289557B (en) * 1999-06-17 2007-11-11 Takeda Chemical Industries Ltd A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1157614A (en) * 1994-07-15 1997-08-20 阿斯特拉公司 Process for synthesis of substituted sulphoxides
CN102558148A (en) * 2010-12-15 2012-07-11 山东方明药业股份有限公司 Synthesis process of lansoprazole important intermediate
CN106543146A (en) * 2016-11-10 2017-03-29 石家庄市度智医药科技有限公司 A kind of preparation method of R-lansoprazole

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
右兰索拉唑的合成及精制工艺研究;李玉龙 等;《中国药物化学杂志》;20160430;第26卷(第2期);第136-138页 *

Also Published As

Publication number Publication date
CN106866630A (en) 2017-06-20

Similar Documents

Publication Publication Date Title
US10759776B2 (en) Synthesis and resolution of nicotine
EP0836601B1 (en) A process for the optical purification of enantiomerically enriched benzimidazole derivatives
RU2157806C2 (en) Method of synthesis of substituted sulpoxides
EP1020461B1 (en) Magnesium salt of the (-)-enantiomer of omeprazole and its use
CN106866630B (en) A kind of preparation method of R-lansoprazole
CZ297585B6 (en) Novel process for preparing magnesium salt of S-omeprazole trihydrate
ZA200503543B (en) Process for preparing optically pure active compounds
CN102584792A (en) Method for preparing high-purity esomeprazole
CN103044402B (en) Method for synthesizing esomeprazole sodium
CN101092421B (en) New technique for extracting sesamin
CN102372726A (en) Preparation method for sirolimus coarse crystal
CN102351847B (en) Industrial method for refining esomeprazole sodium salt
WO2011098938A1 (en) Novel solvate of dexlansoprazole
CN105399728A (en) Dexlansoprazole treatment method applicable to industrial production
CN111072633A (en) Preparation method of esomeprazole magnesium trihydrate
US8907100B2 (en) Lansoprazole compound and novel preparation method thereof
CN104387368A (en) Method for preparing dexilant
CN104402815B (en) Control method of piperaquine phosphate impurity
JP6325178B2 (en) Improved method of optical purification of esomeprazole
CN106554348A (en) A kind of method for preparing Levpantoprazole Sodium
WO2012104863A2 (en) Process for controlling the content of single enantiomer of omeprazole
CN102432412A (en) Preparation method of chiral sulphoxide proton pump inhibitor or pharmaceutically-acceptable salt thereof
CN110204531B (en) Stable high-purity dexlansoprazole and preparation method thereof
CN110156753B (en) Stable high-purity dexlansoprazole and preparation method thereof
CN116640120A (en) Refining method of dexlansoprazole

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant